Stifel Financial
TERN

Stifel Financial’s Terns Pharmaceuticals TERN Stock Holding History

Stifel Financial’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,148
Closed -$377K – 3802
2026
Q1 		$377K Buy
+7,148
New +$294K ﹤0.01% 3032

Other funds holding TERN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Stifel Financial's TERN Position: Q2 2026 in Review

Stifel Financial sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 7,148 shares — an estimated $377K sold.

Stifel Financial first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $377K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • Stifel Financial reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Stifel Financial sold 7,148 Terns Pharmaceuticals shares in Q2 2026, an estimated $377K.
  • Stifel Financial first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Stifel Financial's Terns Pharmaceuticals position peaked at $377K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.